+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Paclitaxel Injection"

Paclitaxel Injection Global Market Report 2024 - Product Thumbnail Image

Paclitaxel Injection Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Paclitaxel Injection is a chemotherapy drug used to treat breast cancer. It is a semi-synthetic derivative of the natural product Taxol, which is extracted from the bark of the Pacific yew tree. Paclitaxel Injection works by interfering with the growth of cancer cells, preventing them from dividing and spreading. It is usually administered intravenously, and is often used in combination with other drugs to treat advanced stages of breast cancer. Common side effects of Paclitaxel Injection include hair loss, nausea, vomiting, and fatigue. The Paclitaxel Injection market is a highly competitive one, with many companies offering their own versions of the drug. Some of the major players in the market include Bristol-Myers Squibb, Pfizer, Teva Pharmaceuticals, and Mylan. Other companies such as Hospira, Sun Pharmaceuticals, and Dr. Reddy's Laboratories also offer Paclitaxel Injection. Show Less Read more